Company / Book Value per Share
Janux Therapeutics, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$15.441
FY2025
5-year range
$7.734 / $19.028
FY2021-FY2025
Trend
-18.9%
vs FY2024
Sector context
#40 of 211
Health Care
What the data says
Janux Therapeutics, Inc.'s book value per share of $15.441 is higher than 81% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 6 years, ranging from -$15.995 in FY2020 to $19.028 in FY2024.
Based on SEC 10-K filings.
$15.441 in FY2025 with a 3-year CAGR of +25.9%. Top quartile in the Health Care sector.
Improved from $7.823 to $15.441 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +25.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-92.8% below sector average
Key checks
Key Insights
- 3-year CAGR of +25.9%, indicating consistent growth.
- In FY2025, book value per share decreased 18.9% year-over-year.
- Ranks #40 out of 211 companies in the Health Care sector.
- Peak book value per share was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 9.17 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.441 | -18.9% |
| FY2024 | $19.028 | +143.2% |
| FY2023 | $7.823 | +1.1% |
| FY2022 | $7.734 | -50.3% |
| FY2021 | $15.568 | +197.3% |
| FY2020 | -$15.995 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026